Skip to main content
Article
Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol—Rationale, Design, and Baseline Data
Diabetes Care (2019)
  • Maryam Afkarian, University of California, Davis
  • Sarit Polsky, University of Colorado Boulder
  • Afshin Parsa, National Institutes of Health
  • Ronnie Aronson, 4LMC Diabetes & Endocrinology, Toronto, Ontario, Canada
  • Maria Luiza Caramori, University of Minnesota
  • David Z. Cherney, University of Toronto
  • Jill P. Crandall, Albert Einstein College of Medicine
  • Ian H. de Boer, University of Washington
  • Thomas G. Elliott, 9BCDiabetes, Vancouver, British Columbia, Canada
  • Andrzej T. Galecki, University of Michigan
  • Allison B. Goldfine, Harvard University
  • J. Sonya Haw, Emory University
  • Irl B. Hirsch, University of Washington
  • Amy B. Karger, University of Minnesota
  • Ildiko Lingvay, University of Texas Southwestern Medical Center
  • David M. Maahs, Stanford University
  • Janet B. McGill, Washington University in St. Louis
  • Mark E. Molitch, Northwestern University
  • Bruce A. Perkins, Lunenfeld-Tanenbaum Research Institute
  • Rodica Pop-Busui, University of Michigan
  • Marlon Pragnell, JDRF
  • Sylvia E. Rosas, Harvard University
  • Peter Rossing, University of Copenhagen
  • Peter Rossing, Steno Diabetes Center
  • Peter Senior, University of Alberta
  • Ronald J. Sigal, University of Calgary
  • Catherine Spino, University of Michigan
  • Katherine R. Tuttle, University of Washington
  • Katherine R. Tuttle, Providence Health Care
  • Guillermo E. Umpierrez, Emory University
  • Amisha Wallia, Northwestern University
  • Ruth S. Weinstock, State University of New York Upstate Medical University
  • Chunyi Wu, University of Michigan
  • Michael Mauer, University of Minnesota
  • Alessandro Doria, Harvard University
Publication Date
August 1, 2019
DOI
10.2337/dc19-0342
Citation Information
Maryam Afkarian, Sarit Polsky, Afshin Parsa, Ronnie Aronson, et al.. "Preventing Early Renal Loss in Diabetes (PERL) Study: A Randomized Double-Blinded Trial of Allopurinol—Rationale, Design, and Baseline Data" Diabetes Care Vol. 42 Iss. 8 (2019) p. 1454 - 1463
Available at: http://works.bepress.com/katherine-tuttle/225/